Psychiatry
Anxiety in the medically ill: a systematic review of the literature.
22 Jun, 2022 | 11:05h | UTCAnxiety in the Medically Ill: A Systematic Review of the Literature – Frontiers in Psychology
Systematic Review: Music therapy for people with substance use disorders.
22 Jun, 2022 | 11:02h | UTCMusic therapy for people with substance use disorders – Cochrane Library
Summary: Music therapy for people with substance use disorder – Cochrane Library
RCT: Guided, internet based, cognitive behavioral therapy noninferior to individual face-to-face CBT for patients with post-traumatic stress disorder.
21 Jun, 2022 | 11:06h | UTC
Cohort Study: Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse.
21 Jun, 2022 | 10:42h | UTC
Commentary on Twitter
In this Swedish cohort study, individuals with OCD diagnosis had a nearly 4-fold risk of substance use disorders, substance-related criminal convictions or deaths. The association was partially accounted for by shared genetics. https://t.co/BDwKw227FG
— JAMA Network Open (@JAMANetworkOpen) June 6, 2022
Cluster RCT: Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners.
21 Jun, 2022 | 10:29h | UTC
WHO report highlights urgent need to transform mental health and mental health care.
20 Jun, 2022 | 10:47h | UTCNews Release: WHO highlights urgent need to transform mental health and mental health care – World Health Organization
Report: World mental health report: Transforming mental health for all – World Health Organization
Commentary: Urgent Need to Transform Mental Health Care – WHO Says In Largest Review Ever – Health Policy Watch
Commentary on Twitter (thread – click for more)
WHO calls on all stakeholders to work together to deepen the value and commitment given to #MentalHealth, reshape the environments that influence mental health and strengthen the systems that care for people’s mental health: WHO #WorldMentalHealthReport https://t.co/J856BrylBB
— World Health Organization (WHO) (@WHO) June 17, 2022
Cohort Study: Long-term risk of overdose or mental health crisis after opioid dose tapering.
14 Jun, 2022 | 10:53h | UTCLong-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering – JAMA Network Open
Editorial: New Data on Opioid Dose Reduction—Implications for Patient Safety – JAMA Network Open
Systematic Review: Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children.
14 Jun, 2022 | 10:34h | UTCCommentary: Vision Impairment Associated with Greater Depression, Anxiety in Children – HCP Live
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.
14 Jun, 2022 | 10:30h | UTC
Commentary on Twitter
MA of RCTs: In patients with cancer pain no effect of cannabinoid administration on opioid dose was found (MD= −3.8 mg; −10.97 to 3.37) or % change in pain scores (MD=1.84; −2.05 to 5.72) https://t.co/tTckc0z8Oz pic.twitter.com/Gh7LvYRz0n
— PfOL (@psychopharmacol) May 20, 2022
Brief Review: Mental health morbidity, self-harm, and suicide in ICU survivors and caregivers.
13 Jun, 2022 | 08:01h | UTCMental health morbidity, self-harm, and suicide in ICU survivors and caregivers – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
#ICU mental health outcomes? The more we discover, the more we realize we need to care for a vulnerable population!
🧠 mental health morbidity among survivors
🧠 mental health morbidity among caregivers
🧠 risk prediction/mitigation
🧠 future directions
🖇 https://t.co/wo8QdP8Mz9 pic.twitter.com/9jX6h9SdRz— Intensive Care Medicine (@yourICM) June 7, 2022
Study: Most males who die by suicide have no known mental health condition.
13 Jun, 2022 | 07:48h | UTCCommentary: Most Males Who Die by Suicide Have No Known Mental Health Condition – Psychiatric News Alert
Original study: Suicide Among Males Across the Lifespan: An Analysis of Differences by Known Mental Health Status – American Journal of Preventive Medicine
Cohort Study: Long-term outcomes of early use of long-acting injectable antipsychotics in schizophrenia.
13 Jun, 2022 | 07:46h | UTCLong-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia – The Journal of Clinical Psychiatry (link to abstract – $ for full-text)
Related:
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis – The Lancet (link to abstract – $ for full-text)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)
Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study.
10 Jun, 2022 | 11:12h | UTCRelated:
Mental Stress and Its Effects on Vascular Health – Mayo Clinic Proceedings
Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine
Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine
Cardiovascular Events during World Cup Soccer – New England Journal of Medicine
Meta-Analysis: Prevalence of depression among caregivers of cancer patients.
10 Jun, 2022 | 10:33h | UTC
The global landscape of the burden of depressive symptoms/major depression in individuals living with HIV/AIDs and its effect on antiretroviral medication adherence.
10 Jun, 2022 | 10:31h | UTC
Systematic Review: Cannabis-based products for chronic pain.
7 Jun, 2022 | 11:47h | UTCCannabis-Based Products for Chronic Pain: A Systematic Review – Annals of Internal Medicine
Annals Video Summary: Cannabis-Based Products for Chronic Pain: A Systematic Review
Summary for Patients: Cannabis-Based Products for Chronic Pain
Related:
Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders
M-A: Birth outcomes of neonates exposed to marijuana in utero.
Cannabis-related allergies: an international overview and consensus recommendations.
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Review: Considerations for cannabinoids in perioperative care by anesthesiologists.
Review: Cannabis-based Medicines and the Perioperative Physician
Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know
M-A: How do income changes impact on mental health and wellbeing for working-age adults?
7 Jun, 2022 | 11:21h | UTCInvited commentary: The impact of income on mental health
Commentary from the author on Twitter (thread – click for more)
Our 🆕️ #SystematicReview in @TheLancetPH looks at how income changes impact on #MentalHealth & #Wellbeing 💰🧠 We find income likely does have a causal effect on mental health & that effects are much bigger (up to 13x) for moves into/out of poverty [1/5] https://t.co/A4rukCOA4a
— Rachel Thomson (@Rachel_Thomson) June 2, 2022
M-A: The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations.
7 Jun, 2022 | 11:20h | UTCInvited Commentary: The prevalence of comorbid substance use disorders and serious mental illnesses in prisons
Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials.
6 Jun, 2022 | 10:53h | UTC
RCTs: Efficacy, safety, and tolerability of Centanafadine sustained-release tablets in adults with attention-deficit/hyperactivity disorder.
3 Jun, 2022 | 11:21h | UTC
AAP Policy Statement: Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families.
2 Jun, 2022 | 11:00h | UTC
Commentary from one of the authors on Twitter (thread – click for more)
1/New @AmerAcadPeds policy statement led by @DrRachelAlinsky with @jquigleymd @DrScottHadland – Terminology for Substance Use Disorders in the Care of Children, Adolescents, Young Adults, and Families.
I'm proud to be a part & there's a cool backstory!https://t.co/CkxtS9BYxN
— Stephen Patrick, MD, MPH (@stephenwpatrick) May 25, 2022
M-A: Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response.
2 Jun, 2022 | 10:32h | UTCAntidepressants in children and adolescents with major depressive disorder and the influence of placebo response: A meta-analysis – Journal of Affective Disorders (link to abstract – $ for full-text)
Commentaries:
Antidepressant Effect Sizes Modest for Pediatric Major Depressive Disorder – Consultant360
Commentary on Twitter
MA: The SMD among all studies of antidepressants in C&A with MDD was 0.12 (0.08-0.17), a very small ES, lower than that seen in studies of adults with MDD. When the MA was limited to studies with a low mean placebo response, the SMD increased to 0.19 https://t.co/hPYvta4rgf
— PfOL (@psychopharmacol) March 23, 2022
Cohort Study: Evaluation of neurologic and psychiatric outcomes after hospital discharge among adult survivors of cardiac arrest.
2 Jun, 2022 | 10:15h | UTC
M-A: Prevalence and correlates of suicide and nonsuicidal self-injury in children.
31 May, 2022 | 10:48h | UTCPrevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children: A Systematic Review and Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
In this meta-analysis of self-harm in children, suicidal ideation, #suicide attempts and nonsuicidal self-injury occurred at concerning rates. Males, child maltreatment, ADHD and depression may be linked to risk. https://t.co/Nw25EuKfwW @rachel__walsh @AnaSheehan19 @csanzari_
— JAMA Psychiatry (@JAMAPsych) May 25, 2022
Cohort Study: Analysis of neuropsychiatric diagnoses after montelukast initiation.
25 May, 2022 | 11:05h | UTCAnalysis of Neuropsychiatric Diagnoses After Montelukast Initiation – JAMA Network Open
Related:
Adverse drug reactions of montelukast in children and adults – Pharmacology Research & Perspectives
Commentary on Twitter
This cohort study of patients with asthma or allergic rhinitis found montelukast use is associated with higher odds of neuropsychiatric outcomes, including anxiety and insomnia. https://t.co/HAzcADsHZc
— JAMA Network Open (@JAMANetworkOpen) May 24, 2022